Compare BOH & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOH | CLDX |
|---|---|---|
| Founded | 1897 | N/A |
| Country | United States | United States |
| Employees | 1877 | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.1B |
| IPO Year | N/A | 1995 |
| Metric | BOH | CLDX |
|---|---|---|
| Price | $74.54 | $31.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $81.80 | $44.50 |
| AVG Volume (30 Days) | 318.0K | ★ 1.0M |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $15.66 | $111.39 |
| Revenue Next Year | $7.82 | $235.85 |
| P/E Ratio | $17.08 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $57.45 | $14.40 |
| 52 Week High | $80.61 | $34.52 |
| Indicator | BOH | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 57.30 |
| Support Level | $69.76 | $23.80 |
| Resistance Level | $78.25 | $34.52 |
| Average True Range (ATR) | 1.45 | 1.74 |
| MACD | 0.36 | -0.11 |
| Stochastic Oscillator | 92.82 | 52.42 |
Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.